Here are relevant reports on : artificial-intelligence-stem-education-market
-
Artificial Retina Market by Type, Product, End-Use Industry and Region - Global Forecast to 2033
The global artificial retina market size was valued at USD million in 2023 and is expected to reach USD million by 2033, with an elevated CAGR during the forecast period of 2023-2033.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Cloud Business Intelligence Market: Worldwide Forecasts and Analysis (2014 – 2019)
Cloud Business Intelligence (BI) is a combination of technologies, tools and solutions that employ one or more cloud deployment models. Business intelligence on cloud is a delivery model that is being watched by many organizations as it offers several advantages in terms of cost benefits, flexibility of implementation, availability and speed of implementation. Cloud computing and business intelligence is an ideal match as business intelligence is about transforming data into information that businesses can use to make better decisions, while cloud computing provides an efficient and agile way to access business intelligence solutions. IBM, SAP, SAS, Salesforce.com, Microsoft, and Oracle are the major players in the cloud business intelligence market. These vendors offer their solutions catering to several industry verticals such as BFSI, retail, healthcare and life sciences, IT and telecommunication, government and public sector, research and education, manufacturing, travel and hospitality, media and communication, and others. The report provides global market trends, overall adoption scenario, competitive landscape, key drivers, restraints, concerns and opportunities in this market. The report aims at estimating the current market size and the future growth potential of this market across various verticals and regions.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Generative AI Outlook 2025 – Shaping the Future of Creative Intelligence
Global IT spending on devices, data center systems, enterprise software, IT services, and communications services is forecast to reach USD 5.7 trillion by 2025 (9.3% growth over 2024). OpenAI, Microsoft, Google, AWS, and Adobe are the major players in generative AI, with more than 45% combined market share in 2024. Other prominent market players are NVIDIA, Meta, Anthropic, Accenture, and IBM. In 2024, key generative AI providers strive to maintain their leadership positions with new product launches & product enhancements, multimodal AI advancements, strategic deals, and partnerships & collaborations. In 2025, Generative AI providers will invest in ethical AI frameworks, real-time multimodal capabilities, and AI democratization to enhance usability, address bias, and ensure data security, meeting the growing demand for personalized, transparent, and scalable AI solutions across industries.
- Published: February 2025
- Price: $ 4950
- TOC Available:
-
Viral Inactivation Market by Product (Kits, Reagents, Systems, Services), Application (Stem Cell, Blood, Tissue, Cell & Gene Therapy), Method (Solvent Detergent, Pasteurization) & End User (Pharmaceutical and Biotechnology, CROs) - Global Forecast to 2021
The global viral inactivation market is segmented on the basis of method, product, application, end user, and geography. By method, the market is divided into solvent detergent method, pasteurization, and other methods. The global viral inactivation market was valued at USD 320.5 Million in 2016. This market is expected to grow at a CAGR of 12.3% to reach USD 573.0 Million in 2021.
- Published: June 2016
- Price: $ 4950
- TOC Available:
-
Virus Filtration Market by Product (Kits & Reagents, Systems, Services), Application (Biologics (Vaccine & Therapeutics, Blood, Tissues, Stem Cells), Devices, Air, Water Purification), End User (Biopharmaceutical, CROs, Research) - Global Forecast to 2020
The global virus filtration market size is projected to grow at a CAGR of 12.3%. Virus filtration is an important operation in the pharmaceutical industry, as it not only ensures if the products are adequately purified and fit for consumption, but also helps to optimize process economics and prevent loss of valuable product.
- Published: April 2016
- Price: $ 4950
- TOC Available:
-
Exosome Diagnostics and Therapeutics Market by Type (Diagnostics, Therapeutics), Product & Service (Instruments, Kits, Reagents), Source (Stem Cells, Blood, Blood Plasma, Urine), Application (Cancer, Musculoskeletal, CVD) - Global Forecast to 2032
The global exosome diagnostics and therapeutics market, valued at US$33 million in 2023, stood at US$59 million in 2024 and is projected to advance at a resilient CAGR of 81.2% from 2024 to 2032, culminating in a forecasted valuation of US$6,848 million by the end of the period. The growth of this market is driven by factors such as the increasing collaborations & commercialization initiatives, emerging potential of exosome-based liquid biopsy, and growing outsourcing of exosome manufacturing activities.
- Published: June 2024
- Price: $ 4950
- TOC Available:
-
3D Cell Culture Market by Product (Scaffolds [Hydrogels, Solid Scaffolds], Scaffold-free [Low Attachment Plates, Microfluidics, Bioprinted]), Application (Cancer, Stem Cell Research, Tissue Engineering), Trends, End User, Region - Global Forecast to 2030
The global 3D cell culture market, valued at US$1.18 billion in 2024, stood at US$1.29 billion in 2025 and is projected to advance at a resilient CAGR of 11.7% from 2024 to 2030, culminating in a forecasted valuation of US$2.26 billion by the end of the period. The market growth is driven by the adoption of personalized medicine globally for multiple diseases and government support & funding for 3D cell culture.
- Published: October 2025
- Price: $ 4950
- TOC Available:
-
Exosome Research Market by Offering (Kits, Reagents (Antibodies, Isolation, Purification), Instruments, Services), Indication (Cancer, Infectious Diseases), Application (Biomarkers, Vaccines), Manufacturing Services (Stem Cell) - Global Forecast to 2030
The global exosome research market, valued at US$189.4 million in 2024, stood at US$214.4 million in 2025 and is projected to advance at a resilient CAGR of 17.5% from 2025 to 2030, culminating in a forecasted valuation of US$480.6 million by the end of the period. The growth of the Asia Pacific exosome research market is primarily due to the growing biomedical industry, increasing life science research, and rising investments by pharmaceutical & biotechnology companies in this region.
- Published: June 2025
- Price: $ 4950
- TOC Available:
-
Neuroblastoma Cancer Market by Diagnostics (MIBG Scan, Imaging, Urine Analysis, Biopsy), Treatment (Surgery, Chemotherapy, Radiation therapy, Stem Cell Transplant, Immunotherapy), Staging, Pipeline, Regulatory, Reimbursement - Global Forecast to 2021
Neuroblastoma is a rare extracranial solid tumor cancer that develops from immature nerve cells found in several areas of the body. It is the most common extracranial solid tumor in childhood.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Cell Harvesting Market by Type (Manual, Automated), Application (Biopharmaceutical, Stem Cell Research), End User (Biotechnology, Biopharmaceutical Companies, Research Institute), and Region (North America, Europe, APAC, Row) - Global Forecasts to 2023
The global cell harvesting market is expected to reach USD 324.5 Million by 2023, at a CAGR of 8.7%. Some of the major players operating in the cell harvesting market are PerkinElmer (US), Brandel (US), TOMTEC (US), Cox Scientific (UK), Connectorate (Switzerland), Scinomix (US), ADSTEC (Japan), and Terumo BCT (a part of Terumo Corporation) (Japan).
- Published: March 2018
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50
